Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial

European Journal of Contraception and Reproductive Health Care

Volumn 21, Issue 3, 2016, Pages 220-226

  Kakaire, Othman ^a   Tumwesigye, Nazarius Mbona ^a   Byamugisha, Josaphat Kayogoza ^a   Gemzell Danielsson, Kristina ^b  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Copper IUD; HIV positive women; intrauterine contraception; IUC acceptability; LNG IUS

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COPPER INTRAUTERINE DEVICE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LIBIDO; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL AROUSAL; SEXUAL FUNCTION; CONTRACEPTION; HUMAN IMMUNODEFICIENCY VIRUS; INTERVIEW; INTRAUTERINE CONTRACEPTIVE DEVICE; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UGANDA; WOMEN'S HEALTH;

CONTRACEPTIVE AGENT; LEVONORGESTREL;

ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HIV; HUMANS; INTERVIEWS AS TOPIC; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; LOGISTIC MODELS; MIDDLE AGED; PATIENT SATISFACTION; UGANDA; WOMEN'S HEALTH;

EID: 84958756326     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2016.1146249     Document Type: Article

References (45)

1. UNAIDS. Global report. UNAIDS report on the global AIDS epidemic 2013 [Internet]. [cited 2015 Jun 25]. Available from: www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf
2. UNAIDS. The gap report, 2014 [Internet]. [cited 2015 Jun 24]. Available from: www.unaids.org/en/resources/campaigns/2014gapreport
3. N.R.Mugo, R.Heffron, D.Donnell,. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-Serodiscordant couples. AIDS 2011;25:1887–1895.
4. R.H.Gray, X.Li, G.Kigozi,. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005;366:1182–1188.
5. S.I.McCoy, R.Buzdugan, L.J.Ralph,. Unmet need for family planning, contraceptive failure, and unintended pregnancy among HIV-infected and HIV-uninfected women in Zimbabwe. PLoS One 2014;e105320.
6. D.Hubacher, I.Mavranezouli, E.McGinn Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. Contraception 2008;78:73–78.
7. M.Mahy, J.Stover, K.Kiragu,. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 2010;86(Suppl. 2):ii48–55.
8. S.R.Hayford, V.Agadjanian, L.Luz Now or never: perceived HIV status and fertility intentions in rural Mozambique. Stud Fam Plann 2012;43:191–199.
9. United Nations Department of Economic and Social Affairs, Population Division. World contraceptive use 2011 [Internet]. [cited 2016 Jan 7]. Available from: http://www.un.org/esa/population/publications/contraceptive2011/contraceptive2011.htm
10. O.Heikinheimo, P.Lehtovirta, I.Aho,. The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study. Am J Obstet Gynecol 2011;204:126.e1–14.
11. O.Heikinheimo, P.Lehtovirta, J.Suni,. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women – effects on bleeding patterns, ovarian function and genital shedding of HIV. Hum Reprod 2006;21:2857–2861.
12. J.Trussell Contraceptive failure in the United States. Contraception 2004;70:89–96.
13. J.Trussell, A.M.Lalla, Q.V.Doan,. Cost effectiveness of contraceptives in the United States. Contraception 2009;79:5–14.
14. Uganda Bureau of Statistics and ICF International, 2012. Uganda demographic and health survey 2011 [Internet]. [cited 2014 Jul 24]. Available from: www.ubos.org/onlinefiles/uploads/ubos/UDHS/UDHS2011.pdf
15. R.Hussain Unintended pregnancy and abortion in Uganda. Issues Brief (Alan Guttmacher Institute) 2013;2:1–8.
16. P.Kisakye, W.O.Akena, G.Kikampikaho,. Factors associated with conception among a sample of HIV-positive women at a hospital in Uganda. Afr J AIDS Res 2009;8:255–260.
17. A.Kaida, L.T.Matthews, S.Kanters,. Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda. PLoS One 2013;8:e63411.
18. UNAIDS. 2014 Progress report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive [Internet]. [cited 2015 Jul 24]. Available from: www.unaids.org/sites/default/files/documents/JC2681_2014-Global-Plan-progress_en.pdf
19. B.J.Oddens Women’s satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999;59:277–286.
20. R.B.Merkatz, M.Plagianos, E.Hoskin,. Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: Development of a model; implications for introduction. Contraception 2014;90:514–521.
21. A.F.Glasier, K.B.Smith, Z.M.van der Spuy,. Amenorrhea associated with contraception—an international study on acceptability Contraception 2003;67:1–8.
22. World Health Organization, Department of Reproductive Health and Research. Medical eligibility criteria for contraceptive use. Geneva: WHO 2010.
23. K.F.Schulz, D.G.Altman, D.Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. BMJ 2010;340:c332.
24. Republic of Uganda Ministry of Health. Sexually transmitted infections. Treatment guidelines for use by operational level health workers in Uganda, 2003 [Internet]. [cited 2015 Jul 24]. Available from: aim.jsi.com/Docs/sti_treatment_guideline_hcp.pdf
25. J.Diaz, L.Bahamondes, I.Monteiro,. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Contraception 2000;62:59–61.
26. J.F.Peipert, Q.Zhao, J.E.Allsworth,. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105–1113.
27. J.Morse, T.Chipato, K.Blanchard,. Provision of long-acting reversible contraception in HIV-prevalent countries: results from nationally representative surveys in southern Africa. BJOG 2013;120:1386–1394.
28. A.Kaida, F.Laher, S.A.Strathdee,. Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services. PloS One 2010;5:e13868.
29. G.Nalwadda, F.Mirembe, J.Byamugisha,. Persistent high fertility in Uganda: young people recount obstacles and enabling factors to use of contraceptives. BMC Public Health 2010;10:530.
30. R.Tewari, V.J.Kay Compliance and user satisfaction with the intra-uterine contraceptive device in family planning service: The results of a survey in Fife, Scotland, August 2004. Eur J Contracep Reproduct Health Care 2006;11:28–37.
31. S.Suhonen, M.Haukkamaa, T.Jakobsson,. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004;69:407V12.
32. L.Haddad, K.M.Wall, B.Vwalika,. Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia. AIDS 2013;27(Suppl. 1):S93–103.
33. P.Enzlin, S.Weyers, D.Janssens,. Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices. J Sex Med 2012;9:1065–1073.
34. L.J.Severy, S.Newcomer Critical issues in contraceptive and STI acceptability. Res J Social Issues 2005;61:45–65.
35. J.A.Higgins, A.R.Davis Contraceptive sex acceptability: a commentary, synopsis and agenda for future research. Contraception 2014;90:4–10.
36. V.Skrzypulec, A.Drosdzol Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system – Mirena. Coll Antropol 2008;32:1059–1068.
37. H.Gorgen, M.Api, A.Akca,. Use of the levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstet 2009;279:835–840.
38. A.A.Ewies Levonorgestrel-releasing intrauterine system – the discontinuing story. Gynecolog Endocrinol 2009;25:668–673.
39. S.H.Perry, P.Swamy, G.A.Preidis,. Implementing the Jadelle implant for women living with HIV in a resource-limited setting: concerns for drug interactions leading to unintended pregnancies. AIDS 2014;28:791–793.
40. J.A.Robinson, R.Jamshidi, A.E.Burke Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol 2012;2012:890160.
41. R.Heffron, D.Donnell, H.Rees,. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012;12:19–26.
42. C.S.Morrison, P.L.Chen, C.Kwok,. Hormonal contraception and the risk of HIV acquisition: an individual participant data metaanalysis. PLoS medicine 2015;12:e1001778.
43. P.Bachanas, A.Medley, S.Pals,. Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia. AIDS Patient Care STDs 2013;27:425–435.
44. L.O.Lawani, A.K.Onyebuchi, C.A.Iyoke Dual method use for protection of pregnancy and disease prevention among HIV-infected women in South East Nigeria. BMC Women Health 2014;14:39.
45. J.Heys, W.Kipp, G.S.Jhangri,. Fertility desires and infection with the HIV: results from a survey in rural Uganda. AIDS 2009;23(Suppl. 1):S37–45.